Results 251 to 260 of about 604,501 (260)

Minimal residual disease in acute myeloid leukaemia

Nature Reviews Clinical Oncology, 2013
Christopher S Hourigan, Judith E Karp
exaly  

Tyrosine kinase inhibitors in chronic myeloid leukaemia: which, when, for whom?

Nature Reviews Clinical Oncology, 2016
Gianantonio Rosti, Fausto Castagnetti, Michele Baccarani   +2 more
exaly  

Signaling by Myeloid C-Type Lectin Receptors in Immunity and Homeostasis

Annual Review of Immunology, 2012
Caetano Reis e Sousa
exaly  

Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia

Cell, 2018
Saar Gill, Michael Klichinsky, Katherine Cummins   +2 more
exaly  

Acute myeloid leukemia management and research in 2025

Ca-A Cancer Journal for Clinicians
Naval Daver, Courtney D DiNardo, Hagop Kantarjian   +2 more
exaly  

Specific and Complex Reprogramming of Cellular Metabolism in Myeloid Cells during Innate Immune Responses

Cell Metabolism, 2017
Leo A.B. Joosten, Rinke Stienstra, Simone Moorlag   +2 more
exaly  

Lo and behold, a role for lomustine in acute myeloid leukemia?

Nature Reviews Clinical Oncology, 2010
Frederick R. Appelbaum
exaly  

Inhibition of Dihydroorotate Dehydrogenase Overcomes Differentiation Blockade in Acute Myeloid Leukemia

Cell, 2016
François E Mercier, Mathias J Wawer, Dongjun Lee   +2 more
exaly  

Tracing the origins of relapse in acute myeloid leukaemia to stem cells

Nature, 2017
Jessie J F Medeiros, Jean Wang, John McPherson   +2 more
exaly  

Myeloid effector cells in cancer

Cancer Cell
Sjoerd H van der Burg, Thorbald van Hall, Tetje van der Sluis   +2 more
exaly